[LUNG ULTRASOUND IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND ACUTE RESPIRATORY FAILURE DUE TO PNEUMONIA.]

Autor: Va, Novikov, G.M. Galstyan, Iaeg, Gemdzh, Ie, Kostina, Mk, Gitis

Publikováno v: Europe PubMed Central

To compare the accuracy of bedside lung ultrasound (LUS) and chest computed tomography (CT) for the de- tection of lung lesions in patients with hematological malignancies and acute respiratory failure (ARF).39 patients with hematological malignancie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9c0a285cda0894791d440c930ae0865c
https://pubmed.ncbi.nlm.nih.gov/29465202

[Differential diagnosis of thymic hyperplasia and mediastinal tumor in patients with lymphogranulomatosis after chemotherapy]

Autor: Tn, Moiseeva, Ls, Al -Radi, Iv, Shitareva, Alexander Shevelev, Ie, Kostina, Sk, Kravchenko, Am, Kremenetskaia, Nn, Tsyba

Publikováno v: Europe PubMed Central

To make differential diagnosis of thymic hyperplasia and mediastinal tumor after chemotherapy (CT) in patients with Hodgkin's disease (HD).The examination of 182 HD patients aged 16-71 years (median 28 years) included chest x-ray computed tomography

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::53892e2a0c87209417076b695666fbb0
https://pubmed.ncbi.nlm.nih.gov/21894751

[Erdheim-Chester disease with cardiac involvement. Case report].

Autor: Latyshev VD; National Research Center for Hematology., Mershina EА; Lomonosov Moscow State University., Kostina IE; National Research Center for Hematology., Sinitsyn VЕ; Lomonosov Moscow State University., Lukina EA; National Research Center for Hematology.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2022 Aug 12; Vol. 94 (7), pp. 897-902. Date of Electronic Publication: 2022 Aug 12.

Gray-zone lymphoma. Examples of rare clinical manifestation.

Autor: Misyurina AE; National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia., Kravchenko SK; National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia., Mangasarova YK; National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia., Magomedova AU; National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia., Kovrigina AM; National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia., Shimanovskaya LT; National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia., Fastova EA; National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia., Misyurin VA; N.N. Blokhin National Medical Cancer Research Center of the Ministry of Health of the Russian Federation, Moscow, Russia., Model SV; National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia., Chebotarev DI; National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia., Kostina IE; National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia., Savchenko VG; National Research Center for Hematology of the Ministry of Health of the Russian Federation, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2019 May 16; Vol. 91 (4), pp. 107-113.

First experience of using Brentuximab vedotin and modified program NHL-BFM-90 in the front-line treatment of patient with anaplastic large-cell lymphoma: a case report and a review of literature.

Autor: Chernova NG; Lymphoma intensive chemotherapy department, National Research Center for Hematology, Russian Federation, Moscow, Russia., Zvonkov EE; Lymphoma intensive chemotherapy department, National Research Center for Hematology, Russian Federation, Moscow, Russia., Badmazhapova DS; Lymphoma intensive chemotherapy department, National Research Center for Hematology, Russian Federation, Moscow, Russia., Sinitsyna MN; Lymphoma intensive chemotherapy department, National Research Center for Hematology, Russian Federation, Moscow, Russia., Grebenyuk LA; Lymphoma intensive chemotherapy department, National Research Center for Hematology, Russian Federation, Moscow, Russia., Sidorova YV; Lymphoma intensive chemotherapy department, National Research Center for Hematology, Russian Federation, Moscow, Russia., Kostina IE; Lymphoma intensive chemotherapy department, National Research Center for Hematology, Russian Federation, Moscow, Russia., Kovrigina AM; Lymphoma intensive chemotherapy department, National Research Center for Hematology, Russian Federation, Moscow, Russia., Obukhova TN; Lymphoma intensive chemotherapy department, National Research Center for Hematology, Russian Federation, Moscow, Russia., Sudarikov AB; Lymphoma intensive chemotherapy department, National Research Center for Hematology, Russian Federation, Moscow, Russia., Savchenko VG; Lymphoma intensive chemotherapy department, National Research Center for Hematology, Russian Federation, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2018 Aug 17; Vol. 90 (7), pp. 77-81.